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ttp://dx.doi.org/10.1016/j.ajpath.2013.09.016It is hypothesized that differential AKT phosphorylation between sexes is important in abdominal aortic
aneurysm (AAA) formation. Male C57BL/6 mice undergoing elastase treatment showed a typical AAA
phenotype (80% over baseline, P < 0.001) and signiﬁcantly increased phosphorylated AKT-308 (p308)
and total-AKT (T-AKT) at day 14 compared with female mice. Elastase-treated Raw cells produced
increased p308 and signiﬁcant amounts of matrix metalloproteinase 9 (MMP-9), and these effects were
suppressed by LY294002 treatment, a known AKT inhibitor. Male and female rat aortic smooth muscle cells
treated with elastase for 1, 6, or 24 hours demonstrated that the p308/T-AKT and AKT-Ser-473/T-AKT
ratios peaked at 6 hours and were signiﬁcantly higher in the elastase-treated cells compared with con-
trols. Similarly, male cells had higher phosphorylated AKT/T-AKT levels than female cells. LY294002 also
inhibited elastase-induced p308 formation more in female smooth muscle cells than in males, and the
corresponding cell media had less proeMMP-9. AKT siRNA signiﬁcantly decreased secretion of proe
MMP-9, as well as proeMMP-2 and active MMP-2 from elastase-treated male rat aortic smooth muscle
cells. IHC of male mice AAA aortas showed increased p308, AKT-Ser-473, and T-AKT compared with
female mice. Aortas from male AAA patients had a signiﬁcantly higher p308/T-AKT ratio than female
AAA tissues. These data suggest that AKT phosphorylation is important in the upstream regulation of
MMP activity, and that differential phosphorylation may be important in sex differences in AAA.
(Am J Pathol 2014, 184: 148e158; http://dx.doi.org/10.1016/j.ajpath.2013.09.016)Supported by NIH grants R01 HL081629-01 and 3R01 HL081629-03S1
(G.R.U.).Abdominal aortic aneurysm (AAA) formation is accompanied
bychronic inﬂammationof the aortawall,withmales four times
more likely to develop the disease than females.1 The activation
of matrix metalloproteinases (MMPs), especially MMP-2 and
MMP-9, has long been known to play a vital role in the
destruction of the aortic wall, leading to AAA development.2e6
However, little is known about upstream modulation of the
MMPs during AAA formation. Activation of the molecules of
the mitogen-activated protein (MAP) kinase pathways is often
observed in inﬂammatory diseases, such as in AAAs. Two
MAP kinases in particular, c-Jun N-terminal kinase (JNK) and
extracellular signaleregulated kinase (ERK), have been shown
to be important in the activation of MMP-2 and MMP-9 in the
aorta.7e10 In addition to theMAPkinase cascade, themolecules
of the phosphoinositide 3-kinase pathway are also known to be
important for themodulation ofMMPs.9,11e15Moreover,AKT,
a key molecule in the phosphoinositide 3-kinase pathway, hasstigative Pathology.
.been shown to play an important role in sex-speciﬁc differences
of various diseases.16e20 The role of AKT in the modulation of
MMPs has not been studied in AAA formation. Therefore,
using an in vivomousemodel of AAA and humanAAA tissue,
as well as in vitro experiments with rat aortic smooth muscle
cells (RASMCs) and Raw cells, we show increased phos-
phorylation of AKT in males compared with females.Materials and Methods
Experimental AAA Formation
Male and female C57BL/6 mice (Jackson Laboratories, Bar
Harbor, ME), aged 8 to 10 weeks, who weighed 20 to 27 g,
AKT and Abdominal Aortic Aneurysmwere used in this study. The experiments were approved by
the University of Michigan (Ann Arbor) Universal Com-
mittee on the Use and Care of Animals (number 8593).
Mice were anesthetized under 2% isoﬂurane inhalational
anesthetic, a midline laparotomy was performed, and the
abdominal aorta from just below the left renal vein to the
bifurcation was isolated.21,22 The aortic diameter (AD) was
measured with a Spot Insight Color Optical Camera (Diag-
nostic Instruments, Sterling Heights, MI) attached to an
operating microscope (SMX-800; Nikon, Melville, NY)
using NIS-Elements software version D.3.10 (Media Cy-
bernetics, Rockville, MD). The aorta was then perfused for 5
minutes with porcine pancreatic elastase (speciﬁc activity 6.6
U/mg protein; E1250; Sigma, St. Louis, MO) at a concen-
tration of 0.332 U/mL in 1 mL isotonic saline (experimental
or control). After aortic perfusion, AD measurements were
obtained. Saline- and elastase-perfused aortas were measured
on 1, 3, and 14 days after perfusion (NZ 5 or 6 per treatment
group per day). Segments of the infrarenal aorta were studied
for Western blot analysis, immunohistochemistry (IHC), and
zymography. AD increases were reported as a percentage
increase from baseline measurements, and an AAA was
deﬁned as a 50% increase in AD compared with baseline.
To investigate whether inhibition of phosphorylation of
AKT with LY294002 could prevent the formation of AAA in
the elastase model, a separate set of experiments was per-
formed, in which mice were divided into four groups, each
withNZ 8mice. The groups of mice were as follows: i) mice
only treated with dimethyl sulfoxide (DMSO) and
LY294002 at a dose of 3 mg/g body weight of mice (No
Surgery group), ii) mice that received elastase perfusion as
described before and also received DMSO treatment (Sur-
gery þ DMSO group but no LY294002), iii) mice that
received elastase perfusion as described before and treated
with LY294002 and DMSO (Surgery þ DMSO þ LY
group), and iv) mice that underwent elastase perfusion as
described earlier (Surgery only group) but received no
LY294002 or DMSO treatment. Treatment of mice consisted
of i.p. injection of LY294002 (dissolved in 25% DMSO in
PBS) at a dose of 3 mg/g body weight of mice every day from
day 4 after elastase perfusion to day 14 (the day the mice were
sacriﬁced and tissue was harvested). DMSO treatment con-
sisted of i.p. injection of 25%DMSO in PBS from day 4 after
elastase perfusion to day 14 to investigate whether DMSO
alone had any effect on AAA formation.
Cell Culture
Male and female RASMCs were isolated, as described pre-
viously,7 and were cultured in high-glucose Dulbecco’s
modiﬁed Eagle’s medium (Invitrogen, Carlsbad, CA) con-
taining 10% fetal calf serum (Invitrogen) and 1% penicillin,
streptomycin, and glutamine mixture (Invitrogen) at 37C in a
humidiﬁed, 5% carbon dioxide atmosphere. Cells (passages 5
to 8) were treated with elastase at 5 mg/mL for 24 hours in
serum-free Dulbecco’s modiﬁed Eagle’s medium containingThe American Journal of Pathology - ajp.amjpathol.orgthe antibiotics and 1% bovine serum albumin. For the in vitro
inhibition studies, the cells were pretreated for 2 hours with 50
mmol/L LY294002, an inhibitor of AKT phosphorylation,
before treatment with elastase. Media were collected at 1, 6,
and 24 hours and assayed forMMP-2 andMMP-9 activities by
zymography. RASMCs were lysed, and total AKT (T-AKT),
phosphorylated AKT-Thr-308 (p308), and AKT-Ser-473
(p473) levels were assessed by using Western blot analysis
(NZ 3 per time point per sample, repeated in triplicate).
siRNA Transfection
Cells were plated in 6-well tissue-culture plates at 60% to
80% conﬂuency. One day later, the cells were transfected
with 1 mmol/L of siRNA per well for AKT1 (Thermo Sci-
entiﬁc, Pittsburgh, PA) or 200 pmol per well for control
siRNA (Santa Cruz Biotechnology, Santa Cruz, CA) using
the Accell siRNA delivery medium for AKT siRNA (Thermo
Scientiﬁc). For control siRNA, siRNA transfection reagent
andmedium fromSantaCruzBiotechnology, according to the
manufacturer’s instructions, were used. Seventy-two hours
after transfection, cells were washed with PBS, starved in
serum-free medium overnight, washed in PBS, and then
treated with elastase-containing media or media alone for a
further 24 hours. The media and cells were then collected for
zymography and Western blot analysis, respectively.
Western Blot Analysis
Proteins were isolated from aortic segments (N Z 3 aortas
per time point per sample, repeated in triplicate) using
radioimmunoprecipitation assay buffer (Thermo Scientiﬁc),
containing 1% SDS by sonication, and overnight incubation
on a shaker. Protein concentration was measured by a
bicinchoninic acid kit (Thermo Scientiﬁc), and equal
amounts of proteins were loaded in each lane for gel elec-
trophoresis using 10% Bis-Tris Nupage gels (Invitrogen).
The electrophoretically separated proteins were transferred
to a polyvinylidene diﬂuoride membrane (Immobilon-P;
Millipore, Billerica, MA) by using a semidry transfer
apparatus (Bio-Rad Laboratories, Hercules, CA), as per the
manufacturer’s guidelines. Non-speciﬁc binding was blocked
by incubating the membrane for 1 hour in StartBlock TBS
(Thermo Scientiﬁc). The membranes were incubated with
primary antibodies in blocking buffer at 4C overnight,
washed with 25 mmol/L Tris, 150 mmol/L NaCl, and 0.05%
Tween-20, pH 7.4, and then incubated with horseradish per-
oxidaseeconjugated secondary antibodies in blocking buffer
for 1 hour, washed in 25mmol/L Tris, 150mmol/L NaCl, and
0.05% Tween-20, pH 7.4, and developed with the West-Pico
electrochemiluminescence kit (Thermo Scientiﬁc). The pri-
mary antibodies used were phosphorylated Akt (Ser473)
(D9E) XP Rabbit monoclonal antibody (mAb) 4060, lot 9,
phosphorylated Akt (Thr308) (C31E5E) Rabbit mAb 2965,
lot 3, Akt (pan) (C67E7) Rabbit mAb 4691, lot 11 (all from
Cell Signaling Technology, Danvers, MA; dilution 1:500),149
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Figure 1 A: Western blot analysis for p308, T-AKT, and b-actin on
proteins isolated from aortas of elastase-treated male (ME) and female (FE)
mice at days 1, 3, and 14, respectively. BeE: Densitometric analysis of the
Western blot in A for p308 and T-AKT at days 3 and 14.
Ghosh et alactin antibody sc-4778 horseradish peroxidase, lot L0908,
and anti-rabbit secondary antibodies (Santa Cruz Biotech-
nology, dilution 1:2000). Mac-2 CL8942AP, lot 4223 (dilu-
tion 1:200) (Cedarlane Laboratories Limited, Burlington,
ON, Canada), anti-rabbit ﬂuorescein isothiocyanate sc-2012,
lot D1009 (dilution 1:200) (Santa Cruz Biotechnology), and
anti-rat Texas Red TI-9400, lot W0322 (dilution 1:200)
(Vector Laboratories, Burlingame, CA), were also used. b-
Actin stainingwas used to check for equal loading of proteins.
Substrate Gel Zymography
Gelatin substrate zymograms were run in precast 10% SDS-
PAGEgels containing 1mg/mL of gelatin (Invitrogen). Equal
volumes of experimental media or equal amounts of proteins
were diluted into 2 Tris-glycine SDS sample buffer and
electrophoretically separated under nonreducing conditions.
Proteins were renatured for 30 minutes in Renaturing Buffer
(Invitrogen) and then the gels were incubated in the Devel-
oping Buffer (Invitrogen) for 30 minutes and again in the
same buffer overnight at 37C. The gel was stained in
SimplyBlue SafeStain (Invitrogen), and the gelatinase activ-
ity was observed by clear bands against the blue background.
IHC Data
Harvested aortas were ﬁxed in fresh 4% paraformaldehyde
for 16 to 24 hours, followed by 70% ethanol. Segments
were then parafﬁn embedded, and sections (5 mm thick)
were mounted onto slides. The sections were deparafﬁnized
and rehydrated according to standard protocols, and those
prepared for IHC studies were treated for 10 minutes with
3% hydrogen peroxide to block endogenous peroxidase
activity. The sections were blocked and then incubated with
the primary antibodies overnight at a dilution of 1:100 in
blocking solution and stained according to the instructions
in the Vectastain ABC Elite Kit (Vector Laboratories). The
immunolocalized proteins were then visualized using the
Novared kit (Vector Laboratories) and imaged using a
Nikon Eclipse Ti microscope (Nikon, Melville, NY).
Human Tissue Preparation
Tissues were obtained from patients undergoing treatment
for AAA (N Z 18) and cadavers (N Z 4) following the
Institutional Review Board guidelines of the University of
Michigan (HUM1999-0413). Proteins were extracted from
aortas using radioimmunoprecipitation assay buffer (Thermo
Scientiﬁc) supplemented with 1% SDS, and protein concen-
tration was measured by a bicinchoninic acid kit (Thermo
Scientiﬁc).
Densitometric Analysis
Densitometric analysis of protein bands in the Western blots
and zymograms were done using ImageJ software version
1.45s (NIH, Bethesda, MD).150Data Analysis
Data are expressed as means  SE. The means of two
groups were compared using a Student’s t-test. P < 0.05
was considered statistically signiﬁcant.
Results
Increased p308 in Mouse AAA Model
The mouse AAA model was used to evaluate the status of
AKT phosphorylation on different days (1, 3, and 14).7,23,24
Western blot data showed that on day 1 after elastase
perfusion, there was no difference in the levels of p308
(P Z 0.43) and T-AKT (P Z 0.35) between male and fe-
male mice (Figure 1A). However, by day 3 after elastase
infusion, there was a signiﬁcant increase in the level of p308
(PZ 0.0002) in male compared with female mice (Figure 1,
A and B), although female mice had 147% more T-AKT
than male mice (Figure 1, A and C). The level of p308 and
T-AKT in male mice at 14 days after elastase infusion was
signiﬁcantly more (P Z 0.0009 and P Z 0.0162, respec-
tively) than in female mice (Figure 1, D and E). The level of
p473 in elastase-treated mice at all time points did not show
any speciﬁc bands (data not shown). Increased phosphory-
lation of AKT in the elastase-perfused aorta in male mice
correlated with increased AAA formation in male compared
with female mice (Figure 2).
Increased Phosphorylation of AKT in Human AAA
Human tissues from AAA and control aortas were analyzed
for their AKT content by using Western blot analysisajp.amjpathol.org - The American Journal of Pathology
Figure 2 Increase in aortic diameter in male (circles) versus female
(triangles) mice at days 1, 3, and 14. P < 0.001. WT, wild type.
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Figure 3 A: Western blot analysis for p308, p473, T-AKT, and b-actin
on proteins extracted from control and abdominal aortic aneurysm (AAA)
human aortas. BeE: Densitometric analysis of the Western blot in A.
AKT and Abdominal Aortic Aneurysm(Figure 3A). AAA patients had signiﬁcantly higher levels of
p308 (P Z 0.0027) (Figure 3B), p473 (P Z 0.0290)
(Figure 3C), and T-AKT (P Z 0.0014) (Figure 3D) than
control tissues (N Z 4). We also observed that the ratio of
p308/T-AKT was signiﬁcantly higher in male (N Z 12)
human AAA tissues compared with female (N Z 6) AAA
tissues (P Z 0.0252) (Figure 3E).
Effect of Inhibiting AKT Phosphorylation on AAA
Formation in Mice
Western blot experiments demonstrate that formation of
AAA in mice and humans was accompanied with an increase
in phosphorylation of AKT. We, therefore, wanted to
investigate whether inhibiting AKT phosphorylation in vivo
would have any effect on AAA formation in mice. We
injected the mice with LY294002 (an inhibitor of AKT
phosphorylation) at only a single dose of 3 mg/g, before
subjecting the mice to elastase perfusion, as described earlier.
We observed that treating mice with LY294002 after elastase
perfusion did not completely inhibit AAA formation (de-
crease of 5.5%) (data not shown). However, Verhoff’se
van Gieson staining, as well as H&E counterstaining, showed
that the elastin ﬁbers were less disrupted in the LY294002-
treated mice compared with those mice that received
DMSO (used to dissolve LY294002) treatment or no drug
treatment (surgery only) (Figure 4).
We next performed IHC to visualize the presence of
p308, p473, and T-AKT in male mice that were treated with
LY294002 after perfusing their aorta with elastase. As seen
in Figure 5, mice that were treated with LY294002 after
elastase perfusion (surgery þ DMSO þ LY) exhibited
reduced staining for p308 and p473 compared with the mice
that received no drug treatments (surgery only and surgery
þ DMSO groups). The staining for T-AKT between these
groups of mice did not show any discernible differences.
We also observed less macrophage inﬁltration in the
LY294002-treated mice than those mice that did not receive
the drug treatment, as demonstrated by less Mac-2 staining,
a known marker for macrophages (Figure 5). Our IHC data
were corroborated with Western blot experiments in which
we observed signiﬁcant differences in p308 and p308/T-
AKT levels in the aortas isolated from the LY294002-
treated mice compared with the DMSO þ surgery andThe American Journal of Pathology - ajp.amjpathol.orgsurgery-only groups of mice (Supplemental Figure S1, B
and D). Moreover, Western blot data showed no differences
in the levels of T-AKT between the different treatment
groups of mice (Supplemental Figure S1C).
Immunoﬂuorescence Analysis of p308 and
Macrophages in Human and Murine AAA Tissues
Western blot data showed that, in both mice and humans,
there was an up-regulation of p308 in the AAA tissues. It is
known that macrophage inﬁltration occurs at the site of AAA
formation.24 We, therefore, used immunoﬂuorescence to
localize p308 and Mac-2 staining in the aorta of the mice that
were either treated or not treated with LY294002 after elas-
tase perfusion. As seen in Figure 6, both in the drug-treated
and untreated groups, there were areas of colocalization of
p308-producing cells and Mac-2 cells, as seen in the merged
immunoﬂuorescence, which exhibited the characteristic yel-
low ﬂuorescence. However, the LY294002-treated mice
showed less yellow ﬂuorescence, indicating less p308 pro-
duction and macrophage inﬁltration in the tissue.
We performed similar experiments on tissues from human
patients with AAA and compared p308 and Mac-2 staining
with those of the control tissues. We observed similar pat-
terns of colocalization of p308 and macrophages in human
AAA tissues (Figure 7) as in mouse experiments. Moreover,
colocalization was observed in both male and female AAA
patients. In control human tissues, we did not observe
colocalization of p308-producing cells and macrophages.151
Figure 4 Verhoff’sevan Gieson and H&E
staining on male mouse aorta showing elastin ﬁ-
bers. A: Aorta from control mice that were only
treated with LY294002 dissolved in DMSO (no
surgery, only DMSO þ LY). B: Elastase-perfused
mouse aorta (surgery only). C: Mice that under-
went elastase perfusion but received only DMSO as
treatment (surgery þ DMSO). D: Mice that under-
went elastase perfusion and were then treated with
LY294002 that was dissolved in DMSO (surgery þ
DMSO þ LY). Arrows show sites of intact and
broken elastin ﬁbers.
Ghosh et alElastase-Induced p308 Formation in RAW Cells Is
Attenuated by LY294002 Treatment
Immunoﬂuorescence studies showed that p308-producing
cells and macrophages were colocalized (Figures 6 and 7) in
the AAA tissues. We, therefore, used in vitro cell culture
assays to determine whether mouse macrophages were
capable of producing p308 on stimulation with elastase.Figure 5 IHC of the mouse aorta from Figure 4. Arrows show areas of decreas
group of mice and steady levels of T-AKT in the three groups of mice.
152Elastase, 5 mg/mL, was used for treating the cells. The dose is
nontoxic and was chosen based on published literature.25e29
As seen in theWestern blot analysis in Figure 8A, when male
mouse macrophages (RAW 264.7 cells) were incubated for
24 hours with elastase, an agent used to induce AAA in our
mouse model, p308, was increased (Figure 8A) compared
with media-treated control cells. This p308 induction was
subsequently abolished when the cells were pretreated withed levels of p308, p473, and macrophages (Mac-2) in the LY294002-treated
ajp.amjpathol.org - The American Journal of Pathology
Figure 6 Immunoﬂuorescence microscopy of the aorta from control
(only surgery) and LY294002-treated (surgery þ DMSO þ LY) group of mice
showing the levels of p308 and presence of macrophages (Mac-2). Arrows
show areas for p308 (green) and Mac-2 (red) stains and the areas of their
colocalization, which exhibited yellow ﬂuorescence. Original magniﬁcation,
100.
AKT and Abdominal Aortic AneurysmLY294002 (Figure 8A). Treatment of macrophages with
elastase for shorter periods of 6 hours (Figure 8A) did not
elicit p308 formation. Western blot analysis also showed that
elastase treatment did not alter T-AKT and actin levels in
these macrophages.
We next investigated whether these macrophages were
capable of secreting MMPs when stimulated with elastase.
As shown by zymography in Figure 8B and densitometric
analysis in Figure 8C, elastase induced signiﬁcant amounts
of MMP-9 secretion from macrophages under in vitroFigure 7 Immunoﬂuorescence microscopy of male and female AAA
patients and control tissues for p308 (green) and macrophages (Mac-2)
(red). The images for p308 and Mac-2 were merged with their nuclear stain
(DAPI, blue) to visualize regions where p308 and Mac-2 colocalize and,
thereby, emit yellow ﬂuorescence. Arrows show areas of p308 and mac-
rophages (Mac-2) and also the sites of their costaining as yellow ﬂuores-
cence. Original magniﬁcation, 400.
The American Journal of Pathology - ajp.amjpathol.orgconditions. However, when the macrophages were pre-
treated with LY294002, an inhibitor for AKT phosphory-
lation, there was a signiﬁcant decrease in MMP-9 secretion
from the macrophages in the presence of elastase.
Elastase-Induced Activation of AKT in Male and Female
RASMCs
Smooth muscle cells (SMCs) are the most abundant cell
type in the aorta. Our immunoﬂuorescence experiments with
mouse and human tissues and a subsequent in vitro exper-
iment with mouse macrophages had shown that the mac-
rophages were able to produce p308 and secrete MMP-9
(Figures 6, 7, and 8). Therefore, in conjunction with mac-
rophages, we wanted to investigate AKT phosphoryla-
tion and MMP-2 and MMP-9 production by aortic
smooth muscle cells when they were treated with elas-
tase and also to observe sex-dependent AKT phosphor-
ylation in the SMCs in response to elastase. Male and
female RASMCs were treated for 1, 6, and 24 hours with
elastase.23 We observed a temporal response to elastase
in that there was an increase in p308 and p473 produc-
tion in both male and female RASMCs, which peaked at
6 hours (Supplemental Figure S2). There was a signiﬁcant
increase in production of p308 (P < 0.0001) (Supplemental
Figures S3, A and B, and S4A) and p473 (P < 0.002)
(Supplemental Figures S3, C and D, and S4C) at 6 and 24
hours. At all time points, male RASMCs had more p308 and
p473 than female RASMCs (Table 1).
Pretreatment of RASMCs with LY294002 Decreases
Elastase-Induced p308 and p473
LY294002 is a known inhibitor of AKT phosphorylation.30
Therefore, to conﬁrm the phosphorylation of AKT in
RASMCs in the presence of elastase, we pretreated
RASMCs with LY294002 for 2 hours and then treated the
cells with elastase in the presence of the inhibitor. As seen in
the Western blot in Supplemental Figure S2, there was a
signiﬁcant reduction in p308 and p473 in female RASMCs
compared with male RASMCs at 6 hours (Table 2).
Elastase Induced Higher ProeMMP-2 Activities in
RASMCs and Attenuation of ProeMMP-9 Induction by
AKT Inhibitor
To determine whether inhibiting AKT phosphorylation had
any effect on MMP-2 and MMP-9 activity, zymography was
performed on the media from the cells treated with either
elastase or elastase in the presence of LY294002. Zymog-
raphy showed that male RASMCs had higher levels of
proeMMP-2 than female RASMCs at all time points after
elastase treatment (Figure 9 and Supplemental Table S1).
Moreover, proeMMP-9 activity at 24 hours was completely
attenuated in female RASMCs by the AKT inhibitor,
LY294002, compared with the male RASMCs (Figure 9).153
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Figure 8 Western blot analysis (A) and zymogram (B) show that
LY294002 inhibits the formation of p308 and MMP-9 secretion in mouse
macrophages (Raw cells) treated with elastase. A: Western blot analysis for
p308, T-AKT, and actin. Lane 1, untreated control cells; 2, cells treated with
LY294002 for 6 hours; 3, cells treated with elastase and LY294002 for 6
hours; 4, cells treated with elastase for 24 hours; and 5, cells treated with
elastase and LY294002 for 24 hours. B: Zymogram with growth medium
from cells as in A. Untreated control cells (control), cells treated with
LY294002 for 24 hours (Inh), cells treated with elastase for 24 hours
(Elast), and cells treated for 24 hours with elastase and LY294002 (Elast þ
Inh). All lanes were run in triplicate. C: Densitometric analysis of the
zymogram in B. *P < 0.005, ****P < 0.0001.
Table 1 Signiﬁcance (P Values) of Levels of p308 and p473 with
Respect to T-AKT in Elastase-Treated Male and Female RASMCs at
Various Times
Time
(hours)
p308/T-AKT P values
(male vs female)
p473/T-AKT P values
(male vs female)
1 0.001 0.005
6 0.022 0.030
24 0.002 0.010
Table 2 Signiﬁcance (P Values) of Levels of p308 and p473 with
Respect to T-AKT in LY294002-Pretreated Male and Female RASMCs
at 6 Hours
Variable P value (male) P value (female)
p308/T-AKT ratio 0.016 0.002
p473/T-AKT ratio 0.117 0.004
Ghosh et alDecreased ProeMMP-2, ProeMMP-9, and Active
MMP-2 in Male RASMCs Transfected with AKT siRNA
In initial experiments, we had shown that use of AKT in-
hibitor, LY294002, prevented male RASMCs from secreting
MMPs into the medium when cells were treated with elastase
(Figure 9). The mechanism of action of pharmacological
inhibitors is often global and may not act solely on one
particular molecule. To better deﬁne this, siRNA technology
was used to selectively inhibit a particular molecule without
affecting any other molecule in a non-speciﬁc manner. We,
thus, transfected male and female RASMCs with siRNA for
AKT and then treated them with elastase for 24 hours. We
observed that AKT siRNA-transfected male RASMCs
secreted less proeMMP-9, proeMMP-2, and active MMP-2
in the presence of elastase than control siRNA-transfected
cells (Figure 10A). Densitometric analysis of the zymo-
gram revealed that AKT siRNA-transfected male RASMCs154secreted signiﬁcantly reduced proeMMP-9 (E versus AKT-
si þ E; P Z 0.0089) (Figure 10B), proeMMP-2 (E versus
AKT-si þ E; PZ 0.0097) (Figure 10C), and active MMP-2
(E versus AKT-si þ E; P Z 0.0020) (Figure 10D). Trans-
fection of female RASMCs with AKT-siRNA did not have
any effect on MMP production in the presence of elastase
(data not shown).
Discussion
AKT, a serine/threonine kinase, was ﬁrst discovered in 1977
as an oncogene in the transforming retrovirus AKT8.31 It is
a critical mediator of extracellular information into intra-
cellular biological responses. AKT regulates a vast array of
cellular responses, such as cell motility, growth, prolifera-
tion, apoptosis, survival, transcription, protein synthesis,
and nutrient metabolism. There are three different AKT
isoforms (AKT1, AKT2, and AKT3), all of which have
similar structural homologies.32 AKT-mutant mice have
shown that mutations in AKT1 may cause schizophrenia.33
AKT2 alterations may result in familial diabetes,34 whereas
changes in AKT3 result in reduced size of the brain.35 AKT
has been shown to be highly activated by low concentra-
tions of insulin in female intra-abdominal adipose tissue
compared with males.36 Cortical phosphorylated AKT was
increased by isoﬂurane in male mice compared with female
mice, and this resulted in better neuroprotection in the male
mice.37 Again, hearts from female mice had greater recovery
of left ventricular function and higher phosphorylated AKT
levels compared with males.38 There are reports showing
that young women have higher levels of nuclear-localized
phosphorylated AKT in cardiomyocytes than comparably
aged men or postmenopausal women.17
Studies have shown that the hormones, estrogen and
testosterone, mediate some of the effects of the AKT. In male
C57BL/6J mice, estrogen confers cardioprotection after
myocardial infarction by decreasing MMP-9 activity and
increasing the AKT signaling pathway.39 Administration ofajp.amjpathol.org - The American Journal of Pathology
Figure 9 Zymogram shows that elastase induces higher proeMMP-2 activities in male RASMCs than female RASMCs. In addition, inhibition of AKT
phosphorylation attenuated proeMMP-9 induction at 24 hours in both male and female RASMCs.
AKT and Abdominal Aortic Aneurysmtestosterone, on the other hand, down-regulated the AKT
pathway in male rat hearts after ischemia/reperfusion.40 Es-
trogen also activates the AKT pathway and induces vascular
endothelial growth factor-A expression in the epithelial cells
of the rat uterus.41 Estrogen also induces endothelial nitric
oxide synthase via an AKT-dependent pathway in vascular
endothelial cells.42 All of these studies suggest that AKT
might play a role in sex-mediated disease differences.
By using the elastase perfusion AAA model, it was
shown that male rats developed larger AAAs than female
rats in association with increased macrophage inﬁltration
and MMP-9 RNA expression in male rats compared with
female rats.23 It was also shown that female rat aortas
transplanted into male rats lost their resistance toward
aneurysm formation and were similar to their male coun-
terparts. Treatment with 17-b-estradiol reduced the growth
of aneurysm, elastin disintegration, macrophage inﬁltration,
and MMP-9 levels in male mice. By using the same elastase
perfusion model, it was demonstrated that oophorectomized
female rats exhibited an increased size of AAAs compared
with oophorectomized female and male rats that received
17-b-estradiol treatment.43 This increased aneurysm for-
mation correlated with increased levels of MMP-2 and
MMP-9 expression in these oophorectomized and 17-b-
estradioletreated male and female mice.44 Moreover, in
earlier research articles, we showed that male mice have
more JNK-1 than female mice, which could account for a
higher incidence of AAA in males.45 We also have shown
that female mice have higher amounts of PAI-1 than male
mice and, thus, PAI-1 could impart resistance to AAA
formation in female mice.46 In another set of in vitro studies,
we have shown that p-ERK signaling is up-regulated in
male rat aortic smooth muscle cells.7 We have also shown
that treatment of male rats with 17-b-estradiol greatly
reduced the male aortic MMP-2 production.47 Our studies
have also documented that there is decreased expression of
multiple cytokines, chemokines, and leukocyte inﬁltration
in female rat aortas compared with male rats in the elastase
perfusion model of AAA.1 Therefore, from all of these
studies, we conclude that female hormones regulate certain
cytokines, chemokines, and proteins, such as JNK and ERK,
having a protective role in aneurysm formation. The present
study suggests that the sex-speciﬁc differences in AKT
phosphorylation and MMP-2 and MMP-9 secretions that weThe American Journal of Pathology - ajp.amjpathol.orgobserved in RASMCs in response to elastase treatment may
be another component of the complex regulatory mecha-
nisms that contribute to the differences that are observed in
male and female animal models of AAA, as well as prob-
ably in humans.
AKT is a known modulator of MMPs.32 Tumor necrosis
factor-a induces MMP-9 expression via activation of the
AKT pathway in vascular smooth muscle cells and in mouse
epidermal cells.11,12,48 The migration of vascular smooth
muscle cells requires phosphorylation of AKT for the acti-
vation of MMP-2 and MMP-9.49 Cigarette smoke extract
has been shown to induce MMP-9 expression in rat alveolar
macrophages via phosphorylation of AKT.50 IL-1einduced
MMP-1 and MMP-13 expressions in human chondrocytes
were blocked by LY294002, suggesting that activation of
AKT is important in cartilage collagenolysis.51
Recently, it was demonstrated that AKT2 confers pro-
tection against aortic aneurysms and dissection.52 Using
AKT2 knockout mice and infusing them with angiotensin II
resulted in the knockout mice forming larger aortic aneu-
rysms compared with the wild-type control. The said study
also demonstrated that there is reduced expression of AKT2
in the degenerative medial layer of human aortic aneurysm
dissection tissues. The angiotensin model of mice that was
used is different from the elastase model of AAA disease in
mice. In the elastase model, we observe aneurysms by day
14, whereas in the angiotensin II model, the mice develop
aneurysm at approximately 28 days, with a more profound
inﬂammatory response. Therefore, the intracellular events in
the angiotensin and elastase model of AAA may not be
comparable. Moreover, the authors did not look into the
expression levels of AKT1 and AKT3 in their study to see
whether the expression levels of these AKT isoforms
differed in the AKT2 knockout mice that underwent angio-
tensin II treatment and also in the human AAA tissues. We
agree with the authors of the previous studies that the
literature documents that a link between AKT isoforms and
inﬂammation is complex and often one isoform compen-
sates for the other.
The present study is the ﬁrst to implicate the importance
of AKT during AAA formation in the elastase model of the
disease in mice. In the present study, AKT phosphorylation
was increased in males compared with females, both in
rodents and in humans. In addition, we document that155
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Figure 10 A: Zymogram depicting decreased MMP-2 and MMP-9 in male
rat aortic smooth muscle cells (RASMCs) transfected with AKT siRNA. BeD:
Densitometric analysis of the zymogram in A. E, cells that were treated with
elastase (5 mg/mL for 24 hours in serum-free DMEM); M, cells that were
treated with serum free DMEM only.
Ghosh et alelastase treatment of the aortic smooth muscle cells differ-
entially turns on the AKT signaling pathway in the male and
female RASMCs. These cells showed increases in
phosphorylated AKT levels with increasing incubation
times with elastase, which peaked at 6 hours. Male SMCs
were more susceptible to increased phosphorylation of
AKT than female cells. Furthermore, at all time points,156phosphorylated AKT levels were higher in male cells than
female cells (Table 1).
Interestingly, inhibiting phosphorylation of AKT with
LY294002 resulted in reduction of proeMMP-9 secretion
by both male and female RASMCs at 24 hours of elastase
treatment. However, treatment of cells with LY294002 did
not have any effect on active MMP-2, as seen in Figure 9.
We next treated the cells with siRNA for AKT, incubated
them with elastase, and performed zymography. Similar
to LY294002, transfection of male RASMCs with siRNA
for AKT and treatment with elastase resulted in a signiﬁ-
cant reduction in proeMMP-9 activity. However, unlike
LY294002, transfection of male RASMCs with AKT siRNA
also resulted in signiﬁcant decreases in proe and active
MMP-2 secretion. Again, such as LY294002, transfection of
female RASMCs with AKT siRNA had no effect on secre-
tion of proe and active MMP-2 into the medium (data not
shown).
In this series of experiments, we ﬁrst used an in vivo
mouse model of AAA to determine the status of AKT in
male and female mice. We observed that, as the disease
progressed, there was a signiﬁcant increase in
phosphorylated AKT in male compared with female mice.
In addition, tissues from male human patients with AAA
had much higher levels of phosphorylated AKT than tissues
from male cadavers. Our immunoﬂuorescence experiments
showed that in both mice with AAA and human tissues from
patients with AAA, p308 levels were higher than in controls
and p308 costained with macrophages. Based on the in vitro
experiments, we also speculate that most of the p308-
producing cells were mainly the smooth muscle cells
because they are the most abundant type of cells in the aorta
and, to a lesser extent, by the macrophages that get recruited
to the site. Likewise, we think that MMP-2 and MMP-9 are
mostly secreted by SMCs, and some MMP-9 is also secreted
by the macrophages at the site of AAA.
Treatment of mice with LY294002, a known AKT phos-
phorylation inhibitor, did not completely abolish AAA for-
mation after elastase perfusion in mice. We speculate that
LY294002 treatment did not inhibit the progression of AAA
formation as the result of either the low dose of LY294002
that was used or the timing of its delivery started 4 days after
AAA induction. Probably, an increased dose of LY294002 or
delivery maintaining a continuous sustained release might
have a greater effect on the progression of AAA in the
elastase model of the disease. Also, pretreatment of mice with
LY294002 for a few days before elastase perfusion may be
able to arrest AAA formation. It is also possible that phos-
phorylation of AKT could be involved in AAA initiation but
not critical for AAA progression. However, we did observe
that LY294002 was able to preserve the elastin ﬁbers in the
aorta, as seen in the Verhoff’sevan Gieson staining
(Figure 4). Also, LY294002 treatment resulted in less p308
and p473 staining in mouse AAA tissues (Figure 5). When
we treated mouse macrophages with elastase under in vitro
conditions, we observed increased levels of p308 and MMP-ajp.amjpathol.org - The American Journal of Pathology
AKT and Abdominal Aortic Aneurysm9 secretion from these cells (Figure 8), which was similar to
our experimental observations with vascular aortic smooth
muscle cells (Figure 9 and Supplemental Figure S2). This
increased production of MMP-9 from the macrophages was
inhibited when the cells were treated with LY294002.
In conclusion, this study shows that, under in vitro con-
ditions, elastase induces phosphorylation of AKT in
RASMCs and there are increased levels of phosphorylated
AKT in male RASMCs compared with female RASMCs.
Elastase-induced differential phosphorylation of AKT in
male and female RASMCs parallels differential activation of
MMPs in RASMCs. Induction of MMP-9 from both male
and female RASMCs by elastase is inhibited by pharma-
cological inhibitors of AKT phosphorylation, whereas the
use of AKT siRNA resulted in inhibition of both MMP-2
and MMP-9 by male RASMCs. This study perhaps at
least partially explains why AAA is more common in men
than women. Although more studies are necessary, the
observation that inhibition of the AKT pathway inhibits
activation of MMPs may lead to the development of new
drugs for the treatment of AAA.
Supplemental Data
Supplemental material for this article can be found at
http://dx.doi.org/10.1016/j.ajpath.2013.09.016.
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